# Cochrane

# Trusted evidence.

# Informed decisions.

# Better health.

# Cochrane Database of Systematic Reviews

# NCT04373473

# Study name

Evaluation of the safety and efficacy of lyophilized fecal microbiota transplantation administered orally for prevention of relapse or intestinal inflammation in adults with ulcerative colitis

# Methods

RCT conducted in the US

# Participants

# Inclusion criteria

- Age ≥ 18 years with history of active UC in the past 12 months based on standard clinical, endoscopic, or histologic criteria
- Clinical remission of UC (Partial Mayo score ≤ 2 with each subscore ≤ 1), on stable maintenance therapy
- Having an attending physician for non-FMT care

# Exclusion criteria

- Inability to take multiple capsules orally
- Pregnancy or lactation
- Exposure to systemic non-topical antibiotics within 14 days of first treatment
- HIV, hepatitis B, or hepatitis C infections
- rCDI or FMT in past 6 months
- Non-IBD active gastrointestinal conditions (e.g. IBS, microscopic colitis, celiac disease, short gut syndrome, colostomy, colectomy, fistulae, strictures, chronic parasitic infections, diverticulitis) or history of bile acid diarrhea
- Immunocompromise (e.g. in setting of primary disorders or due to medication such as oral prednisone > 20 mg/day or prednisone-equivalent)
- Active cancer or ongoing chemotherapy (except for superficial non-metastatic cancers and maintenance chemotherapy) (or both)
- Use of an investigational drug within 90 days of screening visit
- History of significant uncontrolled systemic disease that could interfere with study participation/objectives
- Life expectancy < 1 year

# Interventions

# Experimental arm

- Oral fecal capsules from 3 healthy donors for 12 weeks

# Control arm

- Identical-looking oral capsules for 12 weeks

# Outcomes

# Primary outcome

- Remission (Partial Mayo score ≤ 3) after 12 weeks of treatment at 9 months

# Secondary outcomes

- Quality of life (health-related quality-of-life score) after 12 weeks of treatment at 9 months
- Participant-reported Hospital Anxiety and Depression Scale score after 12 weeks of treatment at 9 months

# Starting date

# Contact information

# Notes

# Fecal transplantation for treatment of inflammatory bowel disease (Review)

Copyright © 2023 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.